Autoimmune encephalitis
Abstract
Treatable syndromes with characteristic clinical featuresKeywords
This publication has 10 references indexed in Scilit:
- Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitisThe Lancet Neurology, 2011
- Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective studyThe Lancet Infectious Diseases, 2010
- Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case seriesThe Lancet Neurology, 2010
- Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotoniaBrain, 2010
- N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexesBrain, 2010
- Cellular and Synaptic Mechanisms of Anti-NMDA Receptor EncephalitisThe Journal of Neuroscience, 2010
- Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesThe Lancet Neurology, 2008
- Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsyNeurology, 2007
- Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibodyNeurology, 2004
- Potassium channel antibody‐associated encephalopathy: a potentially immunotherapy‐responsive form of limbic encephalitisBrain, 2004